Marker Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Marker Therapeutics's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 63% to $3,311,133. The net income raised on -$14,045,895 and profit margin reached -424%. Total operating expenses were $17,892,511.
Profit Margin
| 2014 | 0 | -30.88M | |
|---|---|---|---|
| 2015 | 0 | -34.06M | |
| 2016 | 0 | -2.45M | |
| 2017 | 183.06K | -10.98M | -5999.09% |
| 2018 | 205.99K | -147.95M | -71826.32% |
| 2019 | 213.19K | -20.32M | -9534.57% |
| 2020 | 466.78K | -28.52M | -6111.23% |
| 2021 | 1.24M | -41.87M | -3372.22% |
| 2022 | 9.00M | -29.91M | -332.23% |
| 2023 | 3.31M | -14.04M | -424.2% |
MRKR Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 3.31M | 9.00M | 1.24M | 466.78K | 213.19K | 205.99K | 183.06K | 0 | 0 | 0 |
Cost of revenue | 10.41M | 3.68M | 3.16M | 18.88M | 12.76M | 0 | 5.25M | 0 | 0 | 0 |
Gross profit | -7.10M | 5.32M | -1.92M | -18.41M | -12.55M | 205.99K | -5.06M | 0 | 0 | 0 |
Operating exp. | ||||||||||
Research and development | 10.41M | 26.13M | 27.79M | 18.88M | 12.76M | 123.99M | 5.25M | 3.80M | 1.71M | 189K |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 17.89M | 38.95M | 40.71M | 29.35M | 22.74M | 148.37M | 11.48M | 8.26M | 6.15M | 3.37M |
Operating income | -14.58M | -29.94M | -39.47M | -28.88M | -22.52M | -148.17M | -11.66M | -8.49M | -6.15M | -3.37M |
Other income (expenses), net | 539.15K | 15.08K | -2.40M | 179.74K | 1.10M | -40K | 497.86K | 5.80M | -27.90M | -27.51M |
Income before tax | -14.04M | -29.93M | -41.87M | -28.70M | -21.42M | -147.95M | -10.98M | -2.45M | -34.06M | -30.88M |
Income tax expense | 3.67K | -15.08K | -5.7K | -179.74K | -1.10M | -213.72K | -680.92K | -6.03M | 27.89M | 26.93M |
Net income | -14.04M | -29.91M | -41.87M | -28.52M | -20.32M | -147.95M | -10.98M | -2.45M | -34.06M | -30.88M |
Earnings per share | ||||||||||
Basic EPS | -1.93 | -3.58 | -5.47 | -6.06 | -4.46 | -77.5 | -11.62 | -3.56 | -93.02 | -239.63 |
Diluted EPS | -1.93 | -3.58 | -5.47 | -6.06 | -4.46 | -77.5 | -11.62 | -3.31 | -93.02 | -239.63 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |